510(k) Report

510(k) · Cleared

Cleared

Virtuoso (TM) System for Ihc HER2 (4B5)

K111543510(k) TraditionalCleared Oct 12, 2011132-day reviewClass II21 CFR 864.1860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ventana Medical Systems, Inc. · NOT Microscope, Automated, Image Analysis, Operator Intervention

Cleared on Oct 12, 2011 as substantially equivalent to K080564 (Aperio Technologies, 2009) and 1 other predicate after a 132-day review. Its family tree reaches back 2 generations to 2003. 2 later devices descend from it.

Decided
Oct 12, 2011
Review
132 days
Class
Class II
Product code
NOT
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K032113 (2003). 6 ancestors in all. 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2010: 1 other ancestor2006: 2 other ancestors2004: 1 other ancestor2014: 1 descendant cleared2015: 1 descendant clearedK032113 · Acis (Automated Cellular Imaging System) · Chroma Vision Medical Systems, Inc. · 2003K080564 · Scanscope XT System · Aperio Technologies · 2009200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 3 other ancestors 1 generation forward: 2 descendants K080564 · Scanscope XT System · Aperio Technologies · 2009K032113 · Acis (Automated Cellular Imaging System) · Chroma Vision Medical Systems, Inc. · 20030
  1. Root · 2 generations backK032113 Acis (Automated Cellular Imaging System)Chroma Vision Medical Systems, Inc. · 2003
  2. 1 generation backK080564 Scanscope XT SystemAperio Technologies · 2009
  3. This deviceK111543 Virtuoso (TM) System for Ihc HER2 (4B5)Ventana Medical Systems, Inc. · 2011
  4. Descendant · cites it directly · 0 of its ownK140957 Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd. · 2015
  5. Descendant · cites it directly · 0 of its ownK131140 Omnyx Idp for HER2 Manual ApplicationOmnyx, LLC · 2014

Most influential descendants

Showing 2 of 2 · See all
  • K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd. · 2015 · cites it directly0descendants
  • K131140Omnyx Idp for HER2 Manual ApplicationOmnyx, LLC · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K032113Acis (Automated Cellular Imaging System)Chroma Vision Medical Systems, Inc.2003—
−1K080564Scanscope XT SystemAperio Technologies2009—
0 (this device)K111543Virtuoso (TM) System for Ihc HER2 (4B5)Ventana Medical Systems, Inc.2011—
+1K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd.2015—
+1K131140Omnyx Idp for HER2 Manual ApplicationOmnyx, LLC2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200410
200620
201010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201510
FIG. 1 — Lineage of K111543, 2003–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NOT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NOT device

  1. #1 K260755 OptraSCAN Systemscore 12.2 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K080564Scanscope XT System
Our reading of the summary gave K080654, FDA’s number for Pajunk's Kit for Balloon Aided Laparoscopy (PAJUNK GmbH Medizintechnologie). Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “Aperio ScanScope® XT System”.
Aperio Technologies2009—
*K092333Pathiam System with Iscan for P53 and KI-67
Summary page 1
…nt to the Biolmagene PATHIAMTM System with iScan for p53 and Ki-67 (Biolmagene, Inc., Sunnyvale, CA), cleared under pre-market notification K092333 on October 27, 2010. Both of these systems include the same slide scanner (iScan) and other hardware components. T…
Bioimagene, Inc.2010—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd.20150
K131140Omnyx Idp for HER2 Manual ApplicationOmnyx, LLC20140

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 3 companies; a new generation was cleared every 5.6 years on median.
  • 1 of the 6 ancestors has a recall of any class.
  • Of its descendants, K140957 (Applied Spectral Imaging, Ltd., 2015) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NOT devices

NOT Microscope, Automated, Image Analysis, Operator Intervention: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NOT

1in 2014

2007: 22009: 22011: 12012: 22013: 12014: 12026 (partial year): 1
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NOT

Too few NOT 510(k)s in any year since 2007 to give a median.

Recalls per year · NOT

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NOT

1in 2023

2014: 12015: 12023: 1
2007high 1 (2014) · low 0 (2007)2025

MAUDE reports naming product code NOT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20092—00
20100—00
20111—00
20122—00
20131—00
20141—01
20150—01
20160—00
20170—00
20180—10
20190—00
20200—00
20210—00
20220—00
20230—01
20240—00
20250—00
20261—0—

What is it indicated for?

The Virtuoso system provides automated digital slide creation, management, analysis, and viewing. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting, review and classification of tissues and cells of clinical interest based on particular morphology, color, intensity, size, pattern and shape. The Virtuoso™ System for IHC HER2 (4B35) is for digital read and image analysis applications. This…

Read the full statement (274 words)

The Virtuoso system provides automated digital slide creation, management, analysis, and viewing. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting, review and classification of tissues and cells of clinical interest based on particular morphology, color, intensity, size, pattern and shape.

The Virtuoso™ System for IHC HER2 (4B35) is for digital read and image analysis applications. This particular Virtuoso system is intended for use as an aid to the pathologist in the detection and semi-quantitative measurement of HER2 protein in formalin-fixed, paraffin-embedded normal and neoplastic tissue. This device is an accessory to Ventana Medical Systems, Inc. PATHWAY® anti-HER2/neu (4B35) Rabbit Monoclonal Primary Antibody. The PATHWAY® anti-HER2/neu (4B35) Rabbit Monoclonal Primary Antibody is indicated for use as an aid in the assessment of breast cancer patients for whom HERCEPTIN® (Trastuzumab) treatment is being considered.

NOTE: The IHC HER2 4B35 Digital Read and Image Analysis applications are adjunctive computer-assisted methodologies for the qualified pathologist in the acquisition and measurement of images from microscope glass slides of breast cancer specimens stained for the presence of HER-2/neu receptor protein. The pathologist should verify agreement with the Image Analysis software application score. The accuracy of the test results depends on the quality of the immunohistochemical staining. It is the responsibility of a qualified pathologist to employ appropriate morphological studies and controls as specified in the instructions for the PATHWAY® anti-HER-2/neu (4B35) Rabbit Monoclonal Primary Antibody assay used to assure the validity of the iScan System for IHC HER2 4B35 Digital Read and Image Analysis scores. The actual correlation of PATHWAY® anti-HER-2/neu (4B35) to clinical outcome has not been established.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K111543: Virtuoso (TM) System for Ihc HER2 (4B5).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111543

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026